Multifocal myoclonus as a presentation of levetiracetam toxicity
Background: Levetiracetam (LEV) is widely used for treatment of focal and myoclonic seizures, but reports of LEV toxicity are scarce. Here, we report a rare case of multifocal myoclonus due to LEV toxicity in a patient with chronic renal insufficiency. Case presentation: A 52-year-old woman with his...
Guardado en:
Autores principales: | Mei Bou Nasif, Shweta Varade, Mohamad Z. Koubeissi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e14dbc7b46d04c72afd11431d863c17d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
por: Ja Un Moon, et al.
Publicado: (2021) -
Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
por: Marina Auconi, et al.
Publicado: (2021) -
Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
por: El Sabaa RM, et al.
Publicado: (2020) -
Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
por: Yi ZM, et al.
Publicado: (2018) -
A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
por: Zhang LL, et al.
Publicado: (2018)